MAPT and Alzheimer disease: Also, in the later stages of AD, with advanced levels of Tau pathologies, or in case of pure Tau disease, the TREM2 Arg47His mutation was suggested to slow down damage of neurons through reduced synaptic phagocytosis by the microglia [35].